A B S T R A C T To determine the influence of cardiac ischemia on the activity and subcellular localization of lysosomal cathepsin D, anesthetized rabbits were subjected to ligation of the circumflex coronary artery. Total enzyme activity remained unchanged throughout the 2-h ischemic period, but the subcellular distribution of cathepsin D, as analyzed by biochemical and immunohistochemical techniques, was altered dramatically. A marked increase in nonsedimentable (i.e., 40,000-g supernate) activity developed by 30-45 min and increased further by 2 h. Simultaneously, the immunofluorescent localization of cathepsin D was also changed significantly.
INTRODUCTION
The early biochemical observation that liver ischemia is accompanied by alterations in hepatic lysosomal integrity generated the notion that the release of acid hydrolases into the cytoplasm of acidic and hypoxic cells may precipitate intracellular damage and, ultimately, cell death (1) (2) (3) . Myocardial ischemia has, likewise, been shown to induce analogous alterations in cardiac lysosomes in some (but not all) studies (see 4 for review). Homogenates of ischemic myocardial tissue have revealed a significant redistribution of hydrolytic enzyme activity from the particulate (or sedimentable) state to the soluble (or nonsedimentable) state in several experiments (5) (6) (7) (8) (9) (10) , while depletion of membrane-bound acid phosphatase and aryl sulfatase activity has been demonstrated cytochemically (9) (10) (11) . Based on these changes, it has been postulated that the intracellular release of lysosomal enzymes and their subsequent extralysosomal activity may exercise a pivotal role in the progressive modifications that lead from reversible myocardial ischemia to irreversible infarction.
Although support for the lysosomal hypothesis is attractive, definitive corroboration has been lacking (see 4 for a detailed discussion). Briefly, resolution of the question has been hindered by several factors: (a) traditional methods of homogenizing tissues for subsequent analysis of compartmentalization of lysosomal enzymes, which were originally developed for liver, are not optimal for muscular tissues (12, 13) (15) , and since much acid phosphatase activity as assayed biochemically and histochemically resides outside typical myocytic lysosomes (4, 10, 11, (16) (17) (18) ; and (e) most importantly, until now, published studies have concentrated on changes that appear fairly late after coronary occlusion (i.e., 1 h or more), at a time when irreversible necrosis can be expected already to have appeared in most cells (19) (20) (21) and, thus, at a time when it is impossible to differentiate lysosomal changes that are the result of necrosis from changes that might mediate necrosis. The present study was initiated to reinvestigate the question of how and when cardiac ischemia can alter myocytic lysosomes by taking advantage of two newly developed techniques for studying the distribution oflysosomal cathepsin D, the major acid proteinase of the heart. First, an improved method for homogenizing myocardium was employed to determine biochemically the distribution of enzyme activity between particulate and supernatant fractions (13) . Second, an immunohistochemical method for localizing cathepsin D in cells and tissues (22) (23) (24) was utilized to identify the morphological distribution of the enzyme.
METHODS
Animal care. New Zealand white male rabbits, aged 6-12 wk (body wt = 1.5-2.0 kg), were fed Wayne rabbit chow (Wayne Lab-Blox, Allied Mills, Inc., Chicago, Ill.) ad libitum. The rabbits were anesthetized with sodium pentobarbital (30 mg/kg) and ventilated with a Harvard respirator (Harvard Apparatus Co., Inc., Millis, Mass.). Blood gas partial pressures and pH were maintained within normal ranges throughout the experiments. The chest was opened to expose the left atrium and ventricle, and a 3-0 silk ligature was tied around the circumflex branch of the left coronary artery. The artery was ligated for up to 2 h, and the ischemic area was located visually.
At 0, 30, 45, 60, and 120 min after arterial occlusion, the heart was excised and ischemic tissue displaying cyanosis was removed from the center of the area supplied by the ligated artery. A sample-of distant, presumably nonischemic, left ventricle that appeared grossly normal was removed simultaneously, as was a portion of the right ventricle. Left ventricular tissue in the area of circumflex artery perfusion was also obtained under identical conditions from sham-operated control rabbits which had not been ligated. The tissue samples were immediately placed in ice-cold 0.25 M KCI and half of each sample was homogenized and assayed for cathepsin D and protein, while the other half was used for immunofluorescent and electron microscopy.
Fractionation of heart. Ischemic and control tissues were placed in 10 vol of 0.25 M KC1 and 1 mM EDTA buffered with 0.05 M Tris (pH 7.4) and homogenized for 30 s at 4°C in a Willems Polytron (Brinkmann Instruments, Inc., Westbury, N. Y.) set to rotate at a slow speed (13) . The homogenate was centrifuged at 350 g for 5 min and the pellet, which contained nuclei, tissue fragments, and cell debris, was discarded. The supemate was respun at 40,000 g for 20 min. The second pellet, which contained intact lysosomes, mitochondria, and other organelles, was resuspended in 0.1% Triton X-100 (Rohm & Haas Co., Philadelphia, Pa.) in 0.25 M KCl and vigorously homogenized to release lysosomal enzyme activity. This fraction, termed the "sedimentable" fraction, was assayed for cathepsin D activity as described below. The 40,000g supernate, termed the "nonsedimentable" fraction, was assayed similarly. Results were expressed as the proportion of the 350-g supemate that remained in the 40,000-g supemate (i.e., the ratio of the nonsedimentable to the nonsedimentable-plus-sedimentable activity).
Assay of cathepsin D. Cathepsin D activity was assayed by the method described by Barrett (25) Cathepsin D was localized by either direct or indirect immunofluorescence methods, as described in detail previously (23) , with a specific sheep antiserum for cathepsin D and Fab' antibody subunits to ensure penetration of fixed cell membranes and to minimize nonspecific binding (22, 24) . In the direct method, sections were first treated with sheep anti-(rabbit cathepsin D) Fab' (SaRD Fab') or nonimmune sheep Fab' (Ns Fab') at 5 mg/ml and subsequently stained after washing with fluoresceinated SaRD Fab' at 1 mg/ml. Prior (Fig. 2) . The diffuse cathepsin D staining which radiates away from the nuclear poles (Fig. 2) (Fig. 3) . Examination of such regions at somewhat higher magnification disclosed numerous granules, many of which were markedly enlarged compared to control tissues. Around the larger stained lysosomes, intense halos of diffuse fluorescent material frequently could be detected (Fig. 4) apparent (Fig. 8) , suggesting that the damage was not yet irreversible (19) (20) (21) . Lysosomal structures were enlarged, but their membranes appeared intact. (Fig. 8) 7 Ultrastructurally, myocytes from 45-min sham-operated rabbits disclose regularly organized myofilaments that are typical of cardiac sarcomeres (S), mitochondria (m) with condensed matrices (inset), numerous glycogen granules (g), and a few secondary lysosomes (arrows). Such cells reveal no evidence of ischemic injury. Magnification x 12,500, inset x38,000.
and displayed osmiophilic densities (Fig. 9 ). There was a decrease in the number of visible lysosomal structures and by 2 h they were infrequently observed. been documented only 1 h or more after the onset of participate in causing the progression of potentially coronary occlusion, at a time when irreversible injury reversible injury to necrosis, or whether lysosomal and necrosis have already developed in many of abnormalities are merely the passive result of lethal the affected cells (19) (20) (21) . Consequently it has been damage that has already transpired. Elucidation of the impossible to ascertain whether the lysosomal changes precise role of lysosomal alterations in the progression Cardiac Cathepsin D in Ischemia 917
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1.-N ,,,y .40, V. occlusion. A fuller understanding of the nature and implications of the lysosomal changes demands a precise identification of the anatomical location of the changes at the cellular level. Previous investigations have focused primarily on electron microscopic identification of acid phosphatase and aryl sulfatase (9) (10) (11) . These studies have provided interesting supportive results, but the selection of these enzymes are in some ways less than optimal for the reasons cited earlier.
In the present study, newly developed biochemical and immunohistochemical techniques were employed to obviate some of these problems and to focus on changes involving cathepsin D, a lysosomal proteolytic enzyme that seems likely to be involved (if any lysosomal enzymes are) in tissue destruction under ischemic severely acidic conditions. First, an improved method for homogenizing cardiac tissue to yield maximum numbers of intact lysosomes (13) was utilized. This technique, which uses KC1 rather than the conventional sucrose as the homogenizing solution, provides lower values for nonsedimentable cathepsin D activity than can be obtained otherwise (13) and, thus, makes it easier to observe small changes early in the course of ischemia. Second, a mono-specific antiserum to cathepsin D was employed to distinguish changes occurring in ischemic myocytes from those in interstitial cells (23) .
Although the specific activity of total cathepsin D does not fluctuate meaningfully after ischemia, marked changes are observed in its subcellular distribution. By [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] min after ligation of the circumflex artery, a significant decrease in particulate enzyme activity is detectable biochemically. At the same time, enlarged granules with diffuse fluorescent halos populate ischemic myocytes. It seems plausible that these halos, which become increasingly prominent between 30 and 60 min after occlusion, may represent a morphological depiction of lysosomal damage. As has also been observed by others (21) , electron micrographs of tissue prepared at the same interval only rarely reveal broken lysosomal membranes; therefore, it seems probable that, as a result of changes in membrane permeability, the loss of enzyme from lysosomes may precede the detectable morphological loss of lysosomal membrane integrity (28) . The biochemically detectable redistribution of cathepsin D activity from the particulate to the nonsedimentable fraction of the tissue homogenates may be due both to a release of soluble enzyme in vivo and to the lysosomal population harboring this enzyme becoming more fragile and more readily damaged by homogenization (14) .
Others previously have described changes after 1 or more h of cardiac ischemia in lysosomal enzyme availability, as reflected by alterations in the proportion of enzyme present in nonsedimentable fractions (5) (6) (7) (8) (9) (10) , as well as depletion of acid phosphatase stores as demonstrated histochemically (9) (10) (11) . Our results support these findings and extend them to illustrate that significant changes in cathepsin D localization, as demonstrated both biochemically and immunohistochemically, develop earlier than has previously been demonstrated, i.e., by 30-45 min after coronary occlusion, at or before the time when irreversible necrosis develops (19) (20) (21) . Our results thus strongly support the hypothesis that at least one lysosomal proteinase is released into the cytoplasm of ischemic myocytes early in the course of infarction, and suggest that such release may occur at a time when cellular damage may still be reversible. Subsequently the intracellular activity of that and other proteinases (e.g., cathepsin BL and neutral or alkaline proteinases) may lead to irreversible injury and ultimately myocytic death. It remains unclear whether nonlysosomal neutral and alkaline proteinases that are present in heart and skeletal muscle (29) (30) (31) (32) play an important role in physiological or pathological phenomenon, but because of their pH optima it seems probable that their actions might be blunted, rather than enhanced, by ischemia with its attendant cellular acidosis.
It should be emphasized that our studies do not yet prove a causal role for lysosomal enzyme release in mediating cardiac cell death. It remains possible that an unobserved pivotal event has already occurred before the time lysosomal changes appear. Alterations in ATP levels and in the structure and function of other cell components also develop early in the course of infarction (19) (20) (21) 33) , and it has been suggested, for example, that irreversible damage to mitochondria or to cell membrane integrity may constitute the critical "point of no return." Even if lysosomal activation does indeed precede the point of irreversibility, such a phenomenon could be coincidental rather than causal. Certainly, inasmuch as prolonged ischemia and anoxia fail to accelerate total proteolysis (indeed, the reverse seems to be true [34] ), it seems unlikely that the relation between lysosomal enzymes and cell death can be a simplistic one of increased hydrolytic enzyme release leading to massive and fatal breakdown of the cell. This, of course, is not to say that a more subtle, incomplete hydrolysis by lysosomal enzymes of a few key substances and resultant selective damage to key structures (e.g., mitochondria or cell membranes) could not be fatal to the cell without the need for complete breakdown of all or most of its constituents. Finally, experiments in vitro suggest that lysosomal activation is more closely associated with cardiac reparative processes after an anoxic insult than with the injury process itself (35) , and changes observed in vivo after 30- 
